Health care’s post-pandemic future: ‘There has to be a better way’

Years of discussion and numerous state studies finally brought about the potential for lasting change for two thorny health care issues that had been plaguing the state when Gov. Charlie Baker signed a bill last month: behavioral health care and surprise billing. Yet that progress has left many other longtime goals for state health care…

Read More

Merck acquires newly public Watertown biotech for $1.85B

Life sciences giant Merck is buying Pandion Therapeutics, the autoimmune disorder-focused biotech that went public last July in one of the largest IPOs of 2020, for $1.85 billion in stock. Pandion’s stock price nearly doubled upon the news of the Thursday morning announcement. Read More

Read More